Community Home

Latest Discussion Posts

Please login to see all eligible discussion postings

Either the content you're seeking doesn't exist or it requires proper authentication before viewing.

Community Blogs

  • January ADCES Blog Post – ADA 2023 Standards of Care: Changes to LDL Recommendations Greetings Pharmacy COI Members – January marks a new year and a new set of guidelines from the American Diabetes Association. For the first blog post of the year, I ...

  • Tirzepatide: worth the weight Prepared by: Ana Safri, PharmD PGY2 Ambulatory Care Resident, Boston Medical Center Reviewed by: Katelyn O'Brien, PharmD, BCPS, CDCES, BC-ADM and Courtney Cameron, PharmD What is tirzepatide? Tirzepatide (Mounjaro) ...

    1 person recommends this.
  • Out with the old, in with the new: Lilly to discontinue glucagon emergency kit. How to use: https://uspl.lilly.com/glucagon/glucagon.html#ug As you can see there are many steps to preparing a glucagon kit – time is of the essence in an emergency ...

  • T2DM management complicated by gastroparesis Prepared by: Courtney Cameron, PharmD, PGY2 Ambulatory Care Pharmacy Resident, Boston Medical Center. Reviewed by: Katelyn O'Brien, PharmD, BCPS, CDCES Clinical Pharmacy Specialist, Boston Medical Center. ...

  • FDA approves 2mg dose of Ozempic (semaglutide) for T2DM Titration: 0.25mg weekly x 4 weeks (to avoid GI side effects) 0.5mg weekly as maintenance dose, if tolerating after 4 weeks and need additional glucose control, may increase to 1mg weekly. ...